+1 347 708 0418
Immunohistochemistry (IHC) Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Immunohistochemistry (IHC) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Traditional Direct Method
New Direct Method
Enzyme Bridgemethod
PAP Method
Segment by Application
Hospital
Research Institute
Corporation
Other
By Company
University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Johns Hopkins Hospital
Cleveland Clinic
Dana-Farber/Brigham and Women's Cancer Center
Cedars-Sinai Medical Center
Northwestern Memorial Hospital
Seattle Cancer Care Alliance/University of Washington Medical Center
University of California San Francisco Medical Center
CancerResearchUK
Pfizer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Traditional Direct Method
1.2.3 New Direct Method
1.2.4 Enzyme Bridgemethod
1.2.5 PAP Method
1.3 Market by Application
1.3.1 Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Corporation
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunohistochemistry (IHC) Testing Market Perspective (2017-2028)
2.2 Immunohistochemistry (IHC) Testing Growth Trends by Region
2.2.1 Immunohistochemistry (IHC) Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immunohistochemistry (IHC) Testing Historic Market Size by Region (2017-2022)
2.2.3 Immunohistochemistry (IHC) Testing Forecasted Market Size by Region (2023-2028)
2.3 Immunohistochemistry (IHC) Testing Market Dynamics
2.3.1 Immunohistochemistry (IHC) Testing Industry Trends
2.3.2 Immunohistochemistry (IHC) Testing Market Drivers
2.3.3 Immunohistochemistry (IHC) Testing Market Challenges
2.3.4 Immunohistochemistry (IHC) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunohistochemistry (IHC) Testing Players by Revenue
3.1.1 Global Top Immunohistochemistry (IHC) Testing Players by Revenue (2017-2022)
3.1.2 Global Immunohistochemistry (IHC) Testing Revenue Market Share by Players (2017-2022)
3.2 Global Immunohistochemistry (IHC) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunohistochemistry (IHC) Testing Revenue
3.4 Global Immunohistochemistry (IHC) Testing Market Concentration Ratio
3.4.1 Global Immunohistochemistry (IHC) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunohistochemistry (IHC) Testing Revenue in 2021
3.5 Immunohistochemistry (IHC) Testing Key Players Head office and Area Served
3.6 Key Players Immunohistochemistry (IHC) Testing Product Solution and Service
3.7 Date of Enter into Immunohistochemistry (IHC) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunohistochemistry (IHC) Testing Breakdown Data by Type
4.1 Global Immunohistochemistry (IHC) Testing Historic Market Size by Type (2017-2022)
4.2 Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Type (2023-2028)
5 Immunohistochemistry (IHC) Testing Breakdown Data by Application
5.1 Global Immunohistochemistry (IHC) Testing Historic Market Size by Application (2017-2022)
5.2 Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immunohistochemistry (IHC) Testing Market Size (2017-2028)
6.2 North America Immunohistochemistry (IHC) Testing Market Size by Type
6.2.1 North America Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022)
6.2.2 North America Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028)
6.2.3 North America Immunohistochemistry (IHC) Testing Market Share by Type (2017-2028)
6.3 North America Immunohistochemistry (IHC) Testing Market Size by Application
6.3.1 North America Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022)
6.3.2 North America Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028)
6.3.3 North America Immunohistochemistry (IHC) Testing Market Share by Application (2017-2028)
6.4 North America Immunohistochemistry (IHC) Testing Market Size by Country
6.4.1 North America Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022)
6.4.2 North America Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Immunohistochemistry (IHC) Testing Market Size (2017-2028)
7.2 Europe Immunohistochemistry (IHC) Testing Market Size by Type
7.2.1 Europe Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022)
7.2.2 Europe Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028)
7.2.3 Europe Immunohistochemistry (IHC) Testing Market Share by Type (2017-2028)
7.3 Europe Immunohistochemistry (IHC) Testing Market Size by Application
7.3.1 Europe Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022)
7.3.2 Europe Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028)
7.3.3 Europe Immunohistochemistry (IHC) Testing Market Share by Application (2017-2028)
7.4 Europe Immunohistochemistry (IHC) Testing Market Size by Country
7.4.1 Europe Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022)
7.4.2 Europe Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size (2017-2028)
8.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type
8.2.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application
8.3.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region
8.4.1 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immunohistochemistry (IHC) Testing Market Size (2017-2028)
9.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Type
9.2.1 Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022)
9.2.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028)
9.2.3 Latin America Immunohistochemistry (IHC) Testing Market Share by Type (2017-2028)
9.3 Latin America Immunohistochemistry (IHC) Testing Market Size by Application
9.3.1 Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022)
9.3.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028)
9.3.3 Latin America Immunohistochemistry (IHC) Testing Market Share by Application (2017-2028)
9.4 Latin America Immunohistochemistry (IHC) Testing Market Size by Country
9.4.1 Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022)
9.4.2 Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size (2017-2028)
10.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type
10.2.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application
10.3.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country
10.4.1 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 University of Texas MD Anderson Cancer Center
11.1.1 University of Texas MD Anderson Cancer Center Company Details
11.1.2 University of Texas MD Anderson Cancer Center Business Overview
11.1.3 University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Introduction
11.1.4 University of Texas MD Anderson Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.1.5 University of Texas MD Anderson Cancer Center Recent Developments
11.2 Memorial Sloan Kettering Cancer Center
11.2.1 Memorial Sloan Kettering Cancer Center Company Details
11.2.2 Memorial Sloan Kettering Cancer Center Business Overview
11.2.3 Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Introduction
11.2.4 Memorial Sloan Kettering Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.2.5 Memorial Sloan Kettering Cancer Center Recent Developments
11.3 Mayo Clinic
11.3.1 Mayo Clinic Company Details
11.3.2 Mayo Clinic Business Overview
11.3.3 Mayo Clinic Immunohistochemistry (IHC) Testing Introduction
11.3.4 Mayo Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.3.5 Mayo Clinic Recent Developments
11.4 Johns Hopkins Hospital
11.4.1 Johns Hopkins Hospital Company Details
11.4.2 Johns Hopkins Hospital Business Overview
11.4.3 Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Introduction
11.4.4 Johns Hopkins Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.4.5 Johns Hopkins Hospital Recent Developments
11.5 Cleveland Clinic
11.5.1 Cleveland Clinic Company Details
11.5.2 Cleveland Clinic Business Overview
11.5.3 Cleveland Clinic Immunohistochemistry (IHC) Testing Introduction
11.5.4 Cleveland Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.5.5 Cleveland Clinic Recent Developments
11.6 Dana-Farber/Brigham and Women's Cancer Center
11.6.1 Dana-Farber/Brigham and Women's Cancer Center Company Details
11.6.2 Dana-Farber/Brigham and Women's Cancer Center Business Overview
11.6.3 Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Introduction
11.6.4 Dana-Farber/Brigham and Women's Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.6.5 Dana-Farber/Brigham and Women's Cancer Center Recent Developments
11.7 Cedars-Sinai Medical Center
11.7.1 Cedars-Sinai Medical Center Company Details
11.7.2 Cedars-Sinai Medical Center Business Overview
11.7.3 Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Introduction
11.7.4 Cedars-Sinai Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.7.5 Cedars-Sinai Medical Center Recent Developments
11.8 Northwestern Memorial Hospital
11.8.1 Northwestern Memorial Hospital Company Details
11.8.2 Northwestern Memorial Hospital Business Overview
11.8.3 Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Introduction
11.8.4 Northwestern Memorial Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.8.5 Northwestern Memorial Hospital Recent Developments
11.9 Seattle Cancer Care Alliance/University of Washington Medical Center
11.9.1 Seattle Cancer Care Alliance/University of Washington Medical Center Company Details
11.9.2 Seattle Cancer Care Alliance/University of Washington Medical Center Business Overview
11.9.3 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Introduction
11.9.4 Seattle Cancer Care Alliance/University of Washington Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.9.5 Seattle Cancer Care Alliance/University of Washington Medical Center Recent Developments
11.10 University of California San Francisco Medical Center
11.10.1 University of California San Francisco Medical Center Company Details
11.10.2 University of California San Francisco Medical Center Business Overview
11.10.3 University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Introduction
11.10.4 University of California San Francisco Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.10.5 University of California San Francisco Medical Center Recent Developments
11.11 CancerResearchUK
11.11.1 CancerResearchUK Company Details
11.11.2 CancerResearchUK Business Overview
11.11.3 CancerResearchUK Immunohistochemistry (IHC) Testing Introduction
11.11.4 CancerResearchUK Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.11.5 CancerResearchUK Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Immunohistochemistry (IHC) Testing Introduction
11.12.4 Pfizer Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022)
11.12.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Traditional Direct Method
Table 3. Key Players of New Direct Method
Table 4. Key Players of Enzyme Bridgemethod
Table 5. Key Players of PAP Method
Table 6. Global Immunohistochemistry (IHC) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Immunohistochemistry (IHC) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Immunohistochemistry (IHC) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Immunohistochemistry (IHC) Testing Market Share by Region (2017-2022)
Table 10. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Immunohistochemistry (IHC) Testing Market Share by Region (2023-2028)
Table 12. Immunohistochemistry (IHC) Testing Market Trends
Table 13. Immunohistochemistry (IHC) Testing Market Drivers
Table 14. Immunohistochemistry (IHC) Testing Market Challenges
Table 15. Immunohistochemistry (IHC) Testing Market Restraints
Table 16. Global Immunohistochemistry (IHC) Testing Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Immunohistochemistry (IHC) Testing Revenue Share by Players (2017-2022)
Table 18. Global Top Immunohistochemistry (IHC) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunohistochemistry (IHC) Testing as of 2021)
Table 19. Ranking of Global Top Immunohistochemistry (IHC) Testing Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Immunohistochemistry (IHC) Testing Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immunohistochemistry (IHC) Testing Product Solution and Service
Table 23. Date of Enter into Immunohistochemistry (IHC) Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2017-2022)
Table 27. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type (2023-2028)
Table 29. Global Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Immunohistochemistry (IHC) Testing Revenue Share by Application (2017-2022)
Table 31. Global Immunohistochemistry (IHC) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Immunohistochemistry (IHC) Testing Revenue Share by Application (2023-2028)
Table 33. North America Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Immunohistochemistry (IHC) Testing Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 63. University of Texas MD Anderson Cancer Center Company Details
Table 64. University of Texas MD Anderson Cancer Center Business Overview
Table 65. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Product
Table 66. University of Texas MD Anderson Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 67. University of Texas MD Anderson Cancer Center Recent Developments
Table 68. Memorial Sloan Kettering Cancer Center Company Details
Table 69. Memorial Sloan Kettering Cancer Center Business Overview
Table 70. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Product
Table 71. Memorial Sloan Kettering Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 72. Memorial Sloan Kettering Cancer Center Recent Developments
Table 73. Mayo Clinic Company Details
Table 74. Mayo Clinic Business Overview
Table 75. Mayo Clinic Immunohistochemistry (IHC) Testing Product
Table 76. Mayo Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 77. Mayo Clinic Recent Developments
Table 78. Johns Hopkins Hospital Company Details
Table 79. Johns Hopkins Hospital Business Overview
Table 80. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Product
Table 81. Johns Hopkins Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 82. Johns Hopkins Hospital Recent Developments
Table 83. Cleveland Clinic Company Details
Table 84. Cleveland Clinic Business Overview
Table 85. Cleveland Clinic Immunohistochemistry (IHC) Testing Product
Table 86. Cleveland Clinic Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 87. Cleveland Clinic Recent Developments
Table 88. Dana-Farber/Brigham and Women's Cancer Center Company Details
Table 89. Dana-Farber/Brigham and Women's Cancer Center Business Overview
Table 90. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Product
Table 91. Dana-Farber/Brigham and Women's Cancer Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 92. Dana-Farber/Brigham and Women's Cancer Center Recent Developments
Table 93. Cedars-Sinai Medical Center Company Details
Table 94. Cedars-Sinai Medical Center Business Overview
Table 95. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Product
Table 96. Cedars-Sinai Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 97. Cedars-Sinai Medical Center Recent Developments
Table 98. Northwestern Memorial Hospital Company Details
Table 99. Northwestern Memorial Hospital Business Overview
Table 100. Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Product
Table 101. Northwestern Memorial Hospital Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 102. Northwestern Memorial Hospital Recent Developments
Table 103. Seattle Cancer Care Alliance/University of Washington Medical Center Company Details
Table 104. Seattle Cancer Care Alliance/University of Washington Medical Center Business Overview
Table 105. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Product
Table 106. Seattle Cancer Care Alliance/University of Washington Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 107. Seattle Cancer Care Alliance/University of Washington Medical Center Recent Developments
Table 108. University of California San Francisco Medical Center Company Details
Table 109. University of California San Francisco Medical Center Business Overview
Table 110. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Product
Table 111. University of California San Francisco Medical Center Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 112. University of California San Francisco Medical Center Recent Developments
Table 113. CancerResearchUK Company Details
Table 114. CancerResearchUK Business Overview
Table 115. CancerResearchUK Immunohistochemistry (IHC) Testing Product
Table 116. CancerResearchUK Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 117. CancerResearchUK Recent Developments
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Immunohistochemistry (IHC) Testing Product
Table 121. Pfizer Revenue in Immunohistochemistry (IHC) Testing Business (2017-2022) & (US$ Million)
Table 122. Pfizer Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunohistochemistry (IHC) Testing Market Share by Type: 2021 VS 2028
Figure 2. Traditional Direct Method Features
Figure 3. New Direct Method Features
Figure 4. Enzyme Bridgemethod Features
Figure 5. PAP Method Features
Figure 6. Global Immunohistochemistry (IHC) Testing Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Corporation Case Studies
Figure 10. Other Case Studies
Figure 11. Immunohistochemistry (IHC) Testing Report Years Considered
Figure 12. Global Immunohistochemistry (IHC) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Immunohistochemistry (IHC) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Immunohistochemistry (IHC) Testing Market Share by Region: 2021 VS 2028
Figure 15. Global Immunohistochemistry (IHC) Testing Market Share by Players in 2021
Figure 16. Global Top Immunohistochemistry (IHC) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunohistochemistry (IHC) Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Immunohistochemistry (IHC) Testing Revenue in 2021
Figure 18. North America Immunohistochemistry (IHC) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Immunohistochemistry (IHC) Testing Market Size Market Share by Type (2017-2028)
Figure 20. North America Immunohistochemistry (IHC) Testing Market Size Market Share by Application (2017-2028)
Figure 21. North America Immunohistochemistry (IHC) Testing Market Size Share by Country (2017-2028)
Figure 22. United States Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Immunohistochemistry (IHC) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Immunohistochemistry (IHC) Testing Market Size Market Share by Type (2017-2028)
Figure 26. Europe Immunohistochemistry (IHC) Testing Market Size Market Share by Application (2017-2028)
Figure 27. Europe Immunohistochemistry (IHC) Testing Market Size Share by Country (2017-2028)
Figure 28. Germany Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Immunohistochemistry (IHC) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Immunohistochemistry (IHC) Testing Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Immunohistochemistry (IHC) Testing Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Immunohistochemistry (IHC) Testing Market Size Share by Region (2017-2028)
Figure 38. China Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Immunohistochemistry (IHC) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Immunohistochemistry (IHC) Testing Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Immunohistochemistry (IHC) Testing Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Immunohistochemistry (IHC) Testing Market Size Share by Country (2017-2028)
Figure 48. Mexico Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Immunohistochemistry (IHC) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Immunohistochemistry (IHC) Testing Market Size Share by Country (2017-2028)
Figure 54. Turkey Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Immunohistochemistry (IHC) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. University of Texas MD Anderson Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 58. Memorial Sloan Kettering Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 59. Mayo Clinic Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 60. Johns Hopkins Hospital Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 61. Cleveland Clinic Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 62. Dana-Farber/Brigham and Women's Cancer Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 63. Cedars-Sinai Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 64. Northwestern Memorial Hospital Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 65. Seattle Cancer Care Alliance/University of Washington Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 66. University of California San Francisco Medical Center Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 67. CancerResearchUK Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 68. Pfizer Revenue Growth Rate in Immunohistochemistry (IHC) Testing Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Buy
